Treace Medical Concepts, Inc.

Informe acción NasdaqGS:TMCI

Capitalización de mercado: US$483.4m

Treace Medical Concepts Dirección

Dirección controles de criterios 2/4

El CEO de Treace Medical Concepts es John Treace , nombrado en Jul 2014, tiene una permanencia de 10.33 años. compensación anual total es $8.42M, compuesta por 8.1% salario y 91.9% primas, incluidas acciones y opciones de la empresa. posee directamente un 18.7% de las acciones de la empresa, por valor de $90.41M. La antigüedad media del equipo directivo y de la junta directiva es de 3.2 años y 6.8 años, respectivamente.

Información clave

John Treace

Chief Executive Officer (CEO)

US$8.4m

Compensación total

Porcentaje del salario del CEO8.1%
Permanencia del CEO10.3yrs
Participación del CEO18.7%
Permanencia media de la dirección3.2yrs
Promedio de permanencia en la Junta Directiva6.8yrs

Actualizaciones recientes de la dirección

Recent updates

Is Treace Medical Concepts (NASDAQ:TMCI) Using Debt In A Risky Way?

Oct 26
Is Treace Medical Concepts (NASDAQ:TMCI) Using Debt In A Risky Way?

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Screens Well But There Might Be A Catch

Aug 02
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Screens Well But There Might Be A Catch

Treace Medical Concepts (NASDAQ:TMCI) Has Debt But No Earnings; Should You Worry?

Jun 28
Treace Medical Concepts (NASDAQ:TMCI) Has Debt But No Earnings; Should You Worry?

Treace Medical Concepts: Facing Increasing Competitive Pressure

Jun 14

Market Still Lacking Some Conviction On Treace Medical Concepts, Inc. (NASDAQ:TMCI)

Apr 05
Market Still Lacking Some Conviction On Treace Medical Concepts, Inc. (NASDAQ:TMCI)

Does Treace Medical Concepts (NASDAQ:TMCI) Have A Healthy Balance Sheet?

Feb 09
Does Treace Medical Concepts (NASDAQ:TMCI) Have A Healthy Balance Sheet?

Why Investors Shouldn't Be Surprised By Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) 31% Share Price Surge

Jan 04
Why Investors Shouldn't Be Surprised By Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) 31% Share Price Surge

Market Cool On Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Revenues Pushing Shares 46% Lower

Nov 11
Market Cool On Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Revenues Pushing Shares 46% Lower

Analysts Are Updating Their Treace Medical Concepts, Inc. (NASDAQ:TMCI) Estimates After Its Second-Quarter Results

Aug 13
Analysts Are Updating Their Treace Medical Concepts, Inc. (NASDAQ:TMCI) Estimates After Its Second-Quarter Results

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de John Treace en comparación con los beneficios de Treace Medical Concepts?
FechaCompensación totalSalarioIngresos de la empresa
Sep 30 2024n/an/a

-US$62m

Jun 30 2024n/an/a

-US$64m

Mar 31 2024n/an/a

-US$55m

Dec 31 2023US$8mUS$684k

-US$50m

Sep 30 2023n/an/a

-US$48m

Jun 30 2023n/an/a

-US$42m

Mar 31 2023n/an/a

-US$47m

Dec 31 2022US$4mUS$568k

-US$43m

Sep 30 2022n/an/a

-US$45m

Jun 30 2022n/an/a

-US$39m

Mar 31 2022n/an/a

-US$27m

Dec 31 2021US$688kUS$410k

-US$21m

Sep 30 2021n/an/a

-US$12m

Jun 30 2021n/an/a

-US$8m

Mar 31 2021n/an/a

-US$5m

Dec 31 2020US$392kUS$316k

-US$4m

Compensación vs. Mercado: La compensación total de John($USD8.42M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD2.16M).

Compensación vs. Ingresos: La compensación de John ha aumentado mientras la empresa no es rentable.

CEO

John Treace (52 yo)

10.3yrs

Permanencia

US$8,422,635

Compensación

Mr. John T. Treace Founded Treace Medical Concepts, Inc. in 2014 and has been its Chief Executive Officer and Director since July 1, 2014. Before that, Mr. Treace served as Senior Vice President of U.S. Sa...

Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
John Treace
CEO, Founder & Director10.3yrsUS$8.42m18.7%
$ 90.4m
Mark Hair
Chief Financial Officer4.2yrsUS$4.69m0.031%
$ 150.2k
Aaron Berutti
Senior Vice President of Sales3.3yrsUS$3.26m0.0066%
$ 31.7k
Terry Lubben
Chief Operations & Supply Chain Officer3.2yrssin datossin datos
Taylor Erickson
Chief Information Officer2.7yrssin datossin datos
Scot Elder
Chief Legal & Compliance Officer and Corporate Secretary3.1yrssin datos0.050%
$ 240.4k
Nathan Minnich
Senior Vice President of Marketing1.3yrssin datossin datos
Daniel Owens
Chief Human Resources Officer3.8yrssin datos0.0084%
$ 40.8k
Sean Scanlan
Chief Innovation Officer1.8yrssin datos0.056%
$ 270.7k
Shana Zink
Senior Vice President of Clinical Affairs & Reimbursementno datasin datossin datos
Rachel Osbeck
Senior Vice President of Quality Assurance & Regulatory Affairsno datasin datossin datos

3.2yrs

Permanencia media

52yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de TMCI se considera experimentado (3.2 años antigüedad media).

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
John Treace
CEO, Founder & Director10.3yrsUS$8.42m18.7%
$ 90.4m
Lawrence Hamilton
Independent Director4yrsUS$214.79k0.0081%
$ 39.2k
James Treace
Chairman of the Board10.4yrsUS$94.74k2.86%
$ 13.8m
Richard Mott
Independent Director9.7yrsUS$197.26k1.7%
$ 8.2m
John Bakewell
Independent Director4yrsUS$214.79k0.77%
$ 3.7m
Deepti Jain
Independent Director3.1yrsUS$209.79k0.050%
$ 239.3k
Paul Dayton
Member of the Surgeon Advisory Boardno datasin datossin datos
William DeCarbo
Member of the Surgeon Advisory Boardno datasin datossin datos
Daniel Hatch
Member of the Surgeon Advisory Boardno datasin datossin datos
J.P. McAleer
Member of the Surgeon Advisory Boardno datasin datossin datos
W. Smith
Member of the Surgeon Advisory Boardno datasin datossin datos
Robert Santrock
Member of the Surgeon Advisory Boardno datasin datossin datos

6.8yrs

Permanencia media

63.5yo

Promedio de edad

Junta con experiencia: La junta directiva de TMCI se considera experimentada (6.8 años de antigüedad promedio).